MIRA is advancing complementary non-opioid therapies for two of the largest pain markets MIAMI, FLORIDA / ACCESS Newswire / ...

The success of Vertex's opioid alternative Journavx could aid a group of biotechs that aim to take a similar path with NaV1.8 ...

The Oregon Senate on Monday voted to pass a bill aimed at making non-opioid pain treatments more accessible and affordable ...

Shares of Artelo Biosciences rose after the company reported positive data for its first in-human trial for a potential non-opioid treatment for persistent pain. The stock more than doubled to $16.30 ...

Minimizing opioid exposure during and after colorectal surgery can decrease long-term opioid use in some patients, according ...

Adults with advanced cancer had more emergency department visits for uncontrolled pain and opioid-related complications from 2012 to 2017.

Inhibiting FABP5 represents a unique mechanism of action with ART26.12 standing out as a first-in-class candidate in the field of pain management. The Phase 1 Single Ascending Dose (SAD) study was ...

Grants totaling $15 million will expand services for people suffering from opioid use disorder and make it easier to get help ...

Minnesota allocates $15 million to combat opioid abuse, funding treatment and support services across the state, as ...